All In MedTech

Device Trial Radar · NCT01271946

A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System

Last checked: Nov 19, 2026Latest source record: Jan 31, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

351

Actual

Start

Nov 2010

Primary completion

May 2011

Study completion May 2011

Sponsor

Lead sponsor
Arstasis, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 7, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to observe the clinical safety and effectiveness of the ArstasisOne Access System in patients undergoing diagnostic angiographic procedures through the femoral artery.

Conditions

  • Diagnostic Catheterization Access Through a 5F or 6F Femoral Artery Introducer

Interventions

  • Diagnostic catheterization procedureDevice

    Intervention includes diagnostic catheterization procedure involving access through a 5F or 6F introducer in the femoral artery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Observation of Any Site Related Complications Recorded as Either Major or Minor Adverse Events.Time frame: Procedure through 30 days follow-up.
  2. Major Adverse Events Reported as Percentage of Participants With Adverse Events.Time frame: Procedure through 30 day follow-up.
  3. Device SuccessTime frame: Procedure

6 more outcomes with a free account

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • The Cardiovascular Center

    Parker, Arizona

  • Sequoia Hospital

    Redwood City, California

  • P&S Surgical Hospital

    Monroe, Louisiana

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.